Abstract C61: Phase I Study of pazopanib in combination with the investigational hypoxia-targeted drug TH-302.

Journal Article

Full Text

Duke Authors

Cited Authors

  • Meadows, KL; Lee, PH; Riedel, RF; Morse, MA; Uronis, HE; Blobe, GC; George, DJ; Crawford, J; Hurwitz, HI

Published Date

  • November 2013

Published In

  • Clinical Trials

Published By

Digital Object Identifier (DOI)

  • 10.1158/1535-7163.targ-13-c61